Iris Divé

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Clinical Evaluation

Top Venues

Neuro-oncology advances

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Patrick N Harter, Katharina J Weber, Franz L Ricklefs, Richard Drexler, Ulrich Schüller, Marcel Hack, Tim Hanke, Hildegard Dohmen, Till Acker, Andreas von Deimling, Martin Hasselblatt, Iris Divé, Kristian Unger, Joachim P Steinbach, David Capper, Michael W Ronellenfitsch
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation. Neuro-oncology advances 6 (1) (2024)
Iris Divé, Katharina J Weber, Tabea I Hartung, Eike Steidl, Marlies Wagner, Elke Hattingen, Kea Franz, Emmanouil Fokas, Michael W Ronellenfitsch, Ulrich Herrlinger, Patrick N Harter, Joachim P Steinbach
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma. Neuro-oncology advances 5 (1) (2023)
Iris Divé, Kevin Klann, Jonas B Michaelis, Dennis Heinzen, Joachim P Steinbach, Christian Münch, Michael W Ronellenfitsch
Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner. Cell death discovery 8 (1) (2022)